Chondrus crispus (Irish Moss)

Chondrus crispus, commonly called Irish moss, is a red algae rich in carrageenan, a sulfated polysaccharide that modulates inflammatory pathways by inhibiting nitric oxide production. Its exceptionally high mineral density — including iodine, potassium, and calcium — also supports thyroid function and electrolyte balance.

Origin & History

Chondrus crispus, commonly known as Irish moss or carrageen moss, is a red seaweed (Rhodophyta) found on rocky shores in the North Atlantic, particularly around Ireland and the British Isles. The organism is harvested and processed to extract or utilize its whole biomass, with the principal bioactive constituent being carrageenan, a sulfated polysaccharide comprising approximately 55% of its dry weight.

Historical & Cultural Context

The research does not provide information on historical use in traditional medicine systems, duration of traditional use, or specific traditional applications. The sources focus on modern industrial and culinary applications rather than ethnobotanical or traditional medical contexts.

Health Benefits

• Anti-inflammatory potential: In vitro study showed 64.6% nitric oxide inhibition in organic fraction at 100 µg/mL (preliminary evidence only)
• Mineral content: Contains significant minerals including sodium (1200-4270 mg/100g), potassium (1350-3184 mg/100g), calcium (420-1120 mg/100g), and iodine (24.5 mg/100g) (nutritional data only, no clinical trials)
• Antioxidant compounds: Contains phenolic compounds including catechin (2.335 µg/mL), p-coumaric acid (0.581 µg/mL), and gallic acid (1.09 µg/mL) (chemical analysis only, no human studies)
• Protein source: Contains 11-27% protein by dry weight with various amino acids (nutritional composition data only)
• Omega-3 fatty acids: Contains EPA and other fatty acids totaling 14,669 µg/g dry weight (compositional data only, no clinical efficacy shown)

How It Works

Carrageenan and other sulfated polysaccharides in Chondrus crispus inhibit inducible nitric oxide synthase (iNOS), reducing pro-inflammatory nitric oxide signaling, as demonstrated by 64.6% inhibition in the organic fraction at 100 µg/mL in lipopolysaccharide-stimulated macrophage models. The iodine content supports thyroid peroxidase activity, enabling synthesis of thyroxine (T4) and triiodothyronine (T3). Additionally, soluble fiber fractions may modulate TLR4-mediated NF-κB signaling, though this pathway remains under investigation in human models.

Scientific Research

The provided research contains no human clinical trials, randomized controlled trials, or meta-analyses for Chondrus crispus. Only one in vitro study is cited showing nitric oxide inhibition activity, but no PubMed PMIDs are provided. The research notes it is 'well-investigated scientifically' but only as a model species for photosynthesis studies, not for human health applications.

Clinical Summary

Current evidence for Chondrus crispus is predominantly preclinical: the most cited finding is a 64.6% nitric oxide inhibition observed in an in vitro macrophage assay using the organic fraction at 100 µg/mL, which is preliminary and cannot be directly extrapolated to human dosing. Nutritional analyses confirm meaningful mineral concentrations — sodium (1200–4270 mg/100g), potassium (1350–3184 mg/100g), and calcium (420–1120 mg/100g) — though values vary substantially by harvest region and preparation method. Controlled human clinical trials specifically examining Chondrus crispus supplementation for anti-inflammatory or thyroid outcomes are lacking as of the current literature. The overall evidence base is weak and largely mechanistic; health claims made by commercial products significantly outpace the available clinical data.

Nutritional Profile

Per 100g dry weight: Protein 9.4–21.1g (contains essential amino acids including taurine; protein digestibility may be limited by cell wall polysaccharides); Carbohydrates 55–68g, predominantly carrageenan (55–80% of dry weight, a sulfated galactan polysaccharide comprising both kappa- and lambda-carrageenan), with additional xylose and glucose-based polysaccharides; Fat 1–3g (includes polyunsaturated fatty acids, small amounts of EPA ~0.1–0.3g); Dietary fiber 10–33g (largely indigestible sulfated polysaccharides acting as soluble gel-forming fiber); Minerals: Sodium 1200–4270 mg, Potassium 1350–3184 mg, Calcium 420–1120 mg, Magnesium 300–740 mg, Iron 10–89 mg (bioavailability likely low due to polysaccharide binding), Phosphorus 100–270 mg, Iodine ~24.5 mg (exceptionally high; exceeds tolerable upper intake at even small servings — bioavailability is high for iodine from seaweed), Zinc 1.5–5.0 mg, Manganese 2–10 mg, Selenium trace amounts; Vitamins: Vitamin C 1–8 mg, Beta-carotene (provitamin A) 1.2–7.2 mg, Vitamin E (alpha-tocopherol) 0.5–2.0 mg, Vitamin K trace, B-vitamins including riboflavin (B2) 0.3–0.5 mg, folate (B9) ~180–270 µg, and traces of B12 analogues (largely pseudovitamin B12 with uncertain bioactivity); Bioactive compounds: Phenolic compounds including flavonoids and phlorotannins (total phenolic content ~2.5–15 mg GAE/g dry weight depending on extraction solvent); Sulfated polysaccharides (carrageenan) serve as primary bioactive — kappa-carrageenan forms gels, lambda-carrageenan acts as thickener; Mycosporine-like amino acids (MAAs) present at trace levels (UV-protective compounds); Carotenoids including lutein and beta-carotene at low concentrations (~0.5–3.0 mg/100g); Bioavailability notes: Mineral bioavailability is generally reduced by the polysaccharide matrix and may require processing (drying, boiling) to partially release bound minerals; iodine is highly bioavailable and poses a risk of excessive intake; carrageenan is not digestible by human enzymes but may be partially fermented by gut microbiota; protein bioavailability is moderate and improved by heat processing that disrupts cell walls.

Preparation & Dosage

No clinically studied dosage ranges, standardized extract concentrations, or dosing protocols for human use are available in the current research. No information on standardization methods or therapeutic applications is provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other sea vegetables, vitamin D, omega-3 supplements, iodine, mineral complexes

Safety & Interactions

High iodine content poses a risk for individuals with autoimmune thyroid conditions such as Hashimoto's thyroiditis or Graves' disease, as excess iodine can exacerbate both hypothyroidism and hyperthyroidism. The very high sodium content (up to 4270 mg/100g dry weight) is a contraindication concern for individuals managing hypertension or on sodium-restricted diets. Carrageenan has raised gastrointestinal safety questions in some animal studies — including potential gut permeability effects — though degraded carrageenan (poligeenan) is considered more problematic than the food-grade form. Pregnant and breastfeeding individuals should consult a healthcare provider given the high iodine load and limited human safety data.